S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATIN...

por Santini, Valeria, Platzbecker, Uwe, Fenaux, Pierre, Sekeres, Mikkael, Savona, Michael Robert, Madanat, Yazan, Campelo, María Díez, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Belohlavkova, Petra, Sherman, Laurie, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Xia, Qi, Peng, Lixian, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Feller, Faye, Zeidan, Amer M., Komrokji, Rami S.
Publicado 2023

P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS...

por Sekeres, Mikkael, Santini, Valeria, Díez Campelo, María, S. Komrokji, Rami, Fenaux, Pierre, Robert Savona, Michael, Madanat, Yazan, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Belohlavkova, Petra, Regnault, Antoine, Creel, Kristin, Sengupta, Nishan, Sherman, Laurie, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Feller, Faye, M. Zeidan, Amer, Platzbecker, Uwe
Publicado 2023